“Consuming more than 4 cups per day of coffee, compared to consuming less than 2 cups per day, was associated with a 32 percent lower risk of colorectal cancer recurrence,” he highlighted. Abisola M. Oyelereof the Department of Nutrition and Health, Wageningen University. The research, developed in Netherlandswas associated with a lower risk of colorectal cancer (CRC) recurrence and lower mortality in patients who consumed coffee, according to data published in the International Journal of Cancer.
The researchers analyzed 2,113 patientsmen and women of all ages, with Colorectal cancer and with disease in stages I and III, from eleven hospitals in that country between August 2010 and February 2020, who were followed during and after oncological treatment. “The results suggest that coffee consumption may be associated with a lower risk of CRC recurrence and all-cause mortality, although the association between coffee consumption and mortality appeared non-linear,” Oyelere explained.
Previous studies have shown some reduction in the risk of colorectal cancer among people who drank coffee, which has led researchers to study its effect on recurrences of this tumor. Specialists estimate that, although more data is necessary to understand the mechanism, the consumption of this infusion could improve the prognoses.
According to the work, in relation to the benefit between coffee consumption and mortality from all causes, coffee intake, which is considered optimal, was between 3 and 5 cups daily, with lowest risk with 4 cups a day. For some experts, this is due to the properties anti-inflammatory, antioxidant and insulin sensitizing of the product, which could be behind this benefit.
“More studies are necessary because, although existing evidence suggests that coffee consumption can reduce the risk of colorectal cancer, the association with the prognosis of colorectal cancer is still unclear,” maintains the lead academic of the published research.
by RN
Image gallery
